Increased moxifloxacin dosing among MDR-TB patients with low-level resistance to moxifloxacin did not improve treatment outcomes in a tertiary care centre in Mumbai, India

Post Date: 
2019-11-02
   |   
Countries: 
India
   |   
Clinical Sites: 
Hinduja Hospital
Summary: 

Tornheim JA, Gajjar I, Shivakumar SVBY, Gupte AN, Kishore G, Karane M, Rodrigues C, Gupta A, Udwadia ZF. Increased moxifloxacin dosing among MDR-TB patients with low-level resistance to moxifloxacin did not improve treatment outcomes in a tertiary care centre in Mumbai, India. 50th Union World Conference on Lung Health. Hyderabad, India. October 30-November 2, 2019.

Staff: 
Amita Gupta, MD, MHS
Akshay Gupte, PhD, MBBS, MSPH, PhD
Shri Vijay Bala Yogendra Shivakumar, MD
Jeff Tornheim, MD, MPH
See Also: